Lamivudine and Adefovir to Treat Chronic Hepatitis B

NCT00023309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

HBV (Hepatitis B Virus)
Hepatitis B
Hepatitis

Interventions

DRUG: Lamivudine and adefovir
DRUG: Adefovir alone

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)